Systemic Bio is a 3D Systems company, focused on the development of vascularized organ models made out of hydrogels and human cells to be used for drug discovery and development. Its proprietary platform is built with production-level 3D Systems technology, which has at least 10x greater build volume and up to 10x higher resolution than commercially available technologies.

Systemic Bio will leverage its innovative bioprinting solutions in combination with 3D Systems’ Print to Perfusion process to bioprint highly complex, custom-designed, vascularized tissues for its proprietary organ-on-a-chip platform, called h-VIOS (human vascularized integrated organ systems). The h-VIOS organ-on-a-chip platform comprises plates of cellularized or acellular vascularized three-dimensional scaffolds, and accompanying accessories needed for drug testing. Unlike other currently available models which are created from synthetic materials such as silicone, h-VIOS uses hydrogels that much more closely resemble human tissues.